Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C

Table 1

Baseline characteristics of the study population.

Variables
Age (mean ± SD) (yr)	54.3 ± 11.1
Gender (male/female)	316/286
rs12979860 (CC/CT or TT)	422/67
Cirrhosis (%)	91 (15%)
DM (%)	103 (17%)
BMI (kg/m^2)	24.7 ± 3.7
Log HCV-RNA (IU/mL)	5.4 ± 1.0
Genotype 1/2/3/5/6	263/297/9/1/14
WBC (10^3/μL)	5.8 ± 1.7
N-L ratio	1.60 ± 0.89
Platelet (10^4/μL)	17.6 ± 5.9

Available in 489 (81%) and 584 (97%) of patients.
DM: diabetes mellitus; BMI: body mass index; RVR: rapid virological response; WBC: white cell count; N-L ratio: neutrophil-lymphocyte ratio.